Press releases
Company and organisation announcements, as issued
Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation
Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%), including patients previously treated with enfortumab vedotin and pembrolizumab Early antitumor activity also observed in squamous NSCLC, SCLC and prostate cancer SHANGHAI and HANGZHOU, China, Oct. 29,...
Beyond the Familiar in Tokyo's Asakusa: A New Tour Introduces Visitors to Geisha, Hōkan Entertainers and Traditional Craftspeople
You may have passed through Kaminarimon Gate many times without meeting the people who keep Asakusa's culture alive. TOKYO, Oct. 29, 2026 /PRNewswire/ -- Tokyo's Asakusa district is known for Sensō-ji Temple, Nakamise shopping street and Kaminarimon Gate. Beyond these landmarks, a living...
Anguilla Culinary Experience (ACE) Festival Returns April 28-May 2, 2027
ANGUILLA, Oct. 29, 2026 /PRNewswire/ -- Anguilla Culinary Experience (ACE) returns for its sixth year April 28 through May 2, 2027. The festival brings together international guest chefs, food lovers and Anguilla's own culinary talent for five days of collaborative dinners, beachside...
Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, today announced the...